D63.1

Anemia in chronic kidney disease

Anemia in chronic kidney disease (CKD) is a secondary condition characterized by a decrease in the number of red blood cells or the amount of hemoglobin in the blood, primarily occurring as renal function declines. The hallmark pathophysiology is the insufficient production of erythropoietin (EPO) by the peritubular cells of the kidney, which is the primary hormone stimulating red blood cell production in the bone marrow. This typically becomes clinically significant when the glomerular filtration rate (GFR) falls below 60 mL/min/1.73m² (Stage 3 CKD). Beyond EPO deficiency, the condition is exacerbated by absolute or functional iron deficiency, chronic systemic inflammation which increases hepcidin levels (blocking iron absorption and recycling), and reduced red blood cell lifespan due to uremic toxins. Per ICD-10-CM guidelines, this code requires the underlying stage of chronic kidney disease (N18.1-N18.6, N18.9) to be coded first.

Clinical Symptoms

  • Generalized fatigue and lethargy
  • Shortness of breath (dyspnea) on exertion
  • Pale skin, conjunctiva, and nail beds (pallor)
  • Heart palpitations or tachycardia
  • Dizziness or lightheadedness
  • Chest pain (angina), particularly in patients with underlying CAD
  • Cold intolerance
  • Reduced exercise capacity
  • Difficulty concentrating or cognitive 'fog'
  • Insomnia or poor sleep quality

Common Causes

  • Erythropoietin (EPO) deficiency due to loss of renal peritubular cells
  • Absolute iron deficiency from poor intake or GI blood loss
  • Functional iron deficiency (sequestration) driven by elevated hepcidin levels
  • Chronic inflammation associated with the uremic state
  • Reduced red blood cell survival time in the uremic environment
  • Inhibition of erythropoiesis by uremic toxins
  • Frequent blood draws and blood loss during hemodialysis
  • Secondary hyperparathyroidism leading to bone marrow fibrosis

Documentation & Coding Tips

Strict Sequence Requirement for Manifestation Coding

Example: Patient with Stage 4 Chronic Kidney Disease (N18.4) presents for evaluation of chronic fatigue. Lab work confirms hemoglobin of 9.4 g/dL. Assessment: Anemia in Chronic Kidney Disease (D63.1) due to Stage 4 CKD. Both codes captured to reflect clinical complexity and severity of illness.

Billing Focus: Documentation must support the underlying cause (CKD stage) as the primary code, with D63.1 as the secondary manifestation code. Accurate staging of CKD (N18.1-N18.6) is mandatory for proper billing flow.

Explicitly Link Anemia to the CKD Stage

Example: 65-year-old female with long-standing Type 2 Diabetes and associated Stage 3b Chronic Kidney Disease (N18.32). Recent labs show Hgb 10.1, Ferritin 250, TSAT 22%. Diagnosis: Anemia due to CKD stage 3b. Initiating Procrit 10,000 units weekly.

Billing Focus: Use linking language such as due to or associated with to establish the causal relationship between the renal dysfunction and the hematologic deficit.

Document Treatment and Management Plan

Example: CKD Stage 5 on hemodialysis (N18.6, Z99.2). Chronic anemia (D63.1) stable on Aranesp 100mcg every 2 weeks and Venofer 100mg IV with each dialysis session. Hgb target 10-11 g/dL. Monitor iron studies monthly.

Billing Focus: Documentation of active management (ESA therapy or iron supplementation) validates the medical necessity of the diagnosis and supports higher-level E/M coding.

Identify Secondary Causes of Anemia within CKD

Example: Patient with CKD Stage 4 (N18.4) and anemia in CKD (D63.1) also found to have acute blood loss anemia (D62) following GI bleed. Both conditions documented to reflect different etiologies and resource consumption.

Billing Focus: Coding both D63.1 and additional anemia codes (like iron deficiency or acute blood loss) is permitted if both are present and managed, providing a more specific clinical picture.

Incorporate Laboratory Evidence into Clinical Rationale

Example: Diagnosis: Anemia in CKD Stage 4 (D63.1). Rationale: Patient presents with normocytic, normochromic anemia (Hgb 8.9, MCV 88) consistent with erythropoietin deficiency secondary to advanced renal parenchymal disease. Iron stores are replete.

Billing Focus: Including specific lab values (Hgb, Hct, MCV) provides the clinical evidence required by payers to justify the D63.1 diagnosis and subsequent ESA prescriptions.

Relevant CPT Codes

Related Diagnoses

Hierarchy